Risedronate and granulocytopenia Patient Reports February 12, 2012
Risedronate Side Effects Report #5142922-2
Risedronate side effect was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 35 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood creatinine decreased, granulocytopenia, white blood cell count decreased. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with BONALON, FAMOTIDINE, PREDNISOLONE, SULFAMETHOXAZOLE, ALFAROL, PERSANTIN. Patient recovered.Risedronate Side Effects Report #5159320-8
Risedronate side effect was reported by a Physician from JAPAN on Nov 07, 2006. Female patient, 35 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase increased, blood creatinine decreased, condition aggravated, eosinophil count decreased, granulocytopenia, lymphocyte count increased, monocyte count increased, neutrophil count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BONALON, FAMOTIDINE, PREDNISOLONE, SULFAMETHOXAZOLE, ALFAROL, PERSANTIN. Patient recovered.Risedronate Side Effects Report #4939387-X
Risedronate side effect was reported by a Physician from JAPAN on Feb 20, 2006. Female patient, 24 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: granulocytopenia, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with STOGAR, PREDNISOLONE, ALFAROL, GASTROM. Patient recovered.Risedronate Side Effects Report #4956815-4
Risedronate side effect was reported by a Physician from JAPAN on Mar 07, 2006. Female patient, 24 years of age, was diagnosed with osteoporosis
, ulcer
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: granulocytopenia, leukopenia, lymphocyte count increased, lymphocyte percentage decreased, neutropenia. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with STOGAR, ALFAROL, GASTROM, PREDNISOLONE. Patient recovered.
Risedronate and granulocytopenia 